SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.35%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$293M
AUM Growth
+$293M
(+7.2%)
Cap. Flow
+$5.45M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
28.19%
Holding
93
New
21
Increased
25
Reduced
19
Closed
18
Top Buys
| 1 |
Danaher
DHR
|
$4.72M |
| 2 |
Zoetis
ZTS
|
$4.14M |
| 3 |
Thermo Fisher Scientific
TMO
|
$3.78M |
| 4 |
AbbVie
ABBV
|
$3.11M |
| 5 |
Zimmer Biomet
ZBH
|
$2.93M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$9.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.01M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$4.91M |
| 4 |
Merck
MRK
|
$4.81M |
| 5 |
Cardinal Health
CAH
|
$3.9M |
Sector Composition
| 1 | Healthcare | 87% |
| 2 | Financials | 2.99% |
| 3 | Energy | 1.23% |
| 4 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $8.81M | 3% |
45,000
-7,500
| -14% | -$1.47M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $8.75M | 2.98% |
55,000
+10,000
| +22% | +$1.59M |
|
3
Humana
HUM
$36.5B
| $8.53M | 2.9% |
35,000
| – | – |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $8.51M | 2.9% |
45,000
+20,000
| +80% | +$3.78M |
|
|
5
AbbVie
ABBV
$372B
| $8.44M | 2.87% |
95,000
+35,000
| +58% | +$3.11M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.42M | 2.86% |
60,000
-50,000
| -45% | -$7.01M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $8.02M | 2.73% |
55,000
-5,000
| -8% | -$729K |
|
8
Centene
CNC
$14.3B
| $7.74M | 2.63% |
80,000
| – | – |
|
|
WCG
9
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.73M | 2.63% |
45,000
+10,000
| +29% | +$1.72M |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $7.6M | 2.59% |
50,000
-5,000
| -9% | -$760K |
|
11
Boston Scientific
BSX
$156B
| $7.58M | 2.58% |
260,000
+20,000
| +8% | +$583K |
|
12
Baxter International
BAX
$12.7B
| $7.53M | 2.56% |
120,000
+20,000
| +20% | +$1.26M |
|
13
Abbott
ABT
$231B
| $7.47M | 2.54% |
140,000
+40,000
| +40% | +$2.13M |
|
14
Elevance Health
ELV
$71.8B
| $7.12M | 2.42% |
37,500
-2,500
| -6% | -$475K |
|
15
Stryker
SYK
$150B
| $7.1M | 2.42% |
50,000
+20,000
| +67% | +$2.84M |
|
16
Biogen
BIIB
$19.4B
| $7.05M | 2.4% |
22,500
+2,500
| +13% | +$783K |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.98M | 2.37% |
75,000
-10,000
| -12% | -$931K |
|
18
Agilent Technologies
A
$35.7B
| $6.74M | 2.29% |
105,000
+25,000
| +31% | +$1.61M |
|
19
Cigna
CI
$80.3B
| $6.54M | 2.23% |
35,000
-5,000
| -13% | -$935K |
|
20
Molina Healthcare
MOH
$9.8B
| $6.53M | 2.22% |
95,000
+12,500
| +15% | +$859K |
|
21
Gilead Sciences
GILD
$140B
| $6.48M | 2.21% |
80,000
-10,000
| -11% | -$810K |
|
22
Becton Dickinson
BDX
$55.3B
| $6.37M | 2.17% |
32,500
+7,500
| +30% | +$1.47M |
|
23
Revvity
RVTY
$10.5B
| $6.21M | 2.11% |
90,000
+10,000
| +13% | +$690K |
|
24
Incyte
INCY
$16.5B
| $5.25M | 1.79% |
45,000
-15,000
| -25% | -$1.75M |
|
|
25
Danaher
DHR
$147B
| $4.72M | 1.61% |
+55,000
| New | +$4.72M |
|